"So there are legal consequences and legal avenues for people to use that currently exist
Graphical abstract Similar content being viewed by others Introduction Over the past decade, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have demonstrated cardiovascular, renal, and metabolic benefits in patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD) or high cardiovascular (CV) risk, and have subsequently been incorporated into multiple international guidelines [1,2,3]
Semaglutide must deposit into the fat layernot muscle or deeper tissueto absorb predictably into the bloodstream
Semaglutide to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease
Unreconstituted lyophilized powder can be stored at room temperature short-term but remains most stable under refrigeration
Both semaglutide and tirzepatide are FDA-approved medications shown to help patients lose a significant amount of weight when combined with healthy lifestyle changes